Prevention and treatment of myocardial failure

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/59 (2006.01)

Patent

CA 2155009

Method of increasing the strength of contraction in the mammalian heart muscle by administering to the mammal an effective amount of an activated vitamin D compound, i.e., a 1.alpha.-hydroxylated vitamin D compound which binds with the vitamin D receptor and produces a positive inotropic effect in the heart muscle. The activated vitamin D compound may be given as a means to prevent myocardial failure or to treat myocardial failure.

Procédé permettant d'augmenter la puissance des contractions dans le muscle cardiaque d'un mammifère, et consistant à administrer au mammifère une dose efficace d'un composé de vitamine D activé, en d'autres termes un composé de vitamine D 1alpha-hydroxylé qui se lie avec le récepteur de vitamine D et qui produit un effet inotrope positif dans le muscle cardiaque. Le composé de vitamine D activé peut être administré comme un moyen de prévention ou de traitement de l'insuffisance myocardique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Prevention and treatment of myocardial failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention and treatment of myocardial failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and treatment of myocardial failure will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1350381

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.